Diffuse large B-Cell lymphoma

Showing 9 of 0 results

• Real-world treatment patterns and survival outcomes in second and third line settings in large B-cell lymphoma

  ASH Annual Meeting

  • Publication summary
  • Publications
  • Treatment patterns
  • Diffuse large B-Cell lymphoma
• Flatiron Health announces research to be presented at the 2025 American Society of Hematology’s Annual Meeting & Exposition
  • Press releases
  • Multiple myeloma
  • Diffuse large B-Cell lymphoma
  • Chronic lymphocytic leukemia
  • Acute myeloid leukemia
• The bispecific blind spot: Uncovering real-world inequities in diffuse large B-cell lymphoma, follicular lymphoma, and multiple myeloma therapy access

  ASH Annual Meeting

  • Publication summary
  • Publications
  • Multiple myeloma
  • Diffuse large B-Cell lymphoma
• Flatiron Health launches six new hematology AI-powered longitudinal datasets
  • Press releases
  • Multiple myeloma
  • Diffuse large B-Cell lymphoma
• Advancing real-world evidence in diffuse large B-Cell lymphoma: Insights from EHR-derived data in the UK

  ISPOR Europe

  • Publication summary
  • Publications
  • Diffuse large B-Cell lymphoma
• Impact of social determinants of health on mortality in diffuse large B-cell lymphoma (DLBCL) using real-world data

  ASCO Annual Meeting

  • Publication summary
  • Publications
  • Health equity
  • Diffuse large B-Cell lymphoma
• A real-world analysis of the relationship between Epstein-Barr Virus positivity and baseline characteristics, treatment patterns and clinical outcomes in diffuse large B-cell lymphoma

  ASH Annual Meeting

  • Publication summary
  • Publications
  • Diffuse large B-Cell lymphoma
• The COVID-19 pandemic and in-person visit rate disruptions among patients with hematologic neoplasms in the US in 2020 to 2021

  JAMA Network Open

  • Publication summary
  • Publications
  • Treatment patterns
  • Multiple myeloma
  • Diffuse large B-Cell lymphoma
  • Chronic lymphocytic leukemia
• Real-world application of National Comprehensive Cancer Network (NCCN) testing guidelines in diffuse large B-cell lymphoma (DLBCL) results in underdiagnosis of double-hit lymphoma

  ASH Annual Meeting

  • Publications
  • Treatment patterns
  • Diffuse large B-Cell lymphoma